Search Results - "Stropparo, Erica"

Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset by Puthenparampil, Marco, Zito, Antonio, Pantano, Giorgia, Federle, Lisa, Stropparo, Erica, Miante, Silvia, De Silvestro, Giustina, Plebani, Mario, Gallo, Paolo

“…Background: Alteration of T-follicular helper (TFH) and regulatory (TFR) subpopulations may contribute to the development of auto-reactive B-cell. Objective:…”
Get full text

Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis by Puthenparampil, Marco, Stropparo, Erica, Zywicki, Sofia, Bovis, Francesca, Cazzola, Chiara, Federle, Lisa, Grassivaro, Francesca, Rinaldi, Francesca, Perini, Paola, Sormani, Maria Pia, Gallo, Paolo

“…Apart from IgG oligoclonal bands, no other biomarker has, to date, been validated for diagnostic and/or prognostic purposes in multiple sclerosis (MS). To…”
Get full text

NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis by Puthenparampil, Marco, Cazzola, Chiara, Zywicki, Sofia, Federle, Lisa, Stropparo, Erica, Anglani, Mariagiulia, Rinaldi, Francesca, Perini, Paola, Gallo, Paolo

“…Background: Cortical lesions (CLs) are typical of multiple sclerosis (MS) and have been recently incorporated in MS diagnostic criteria. Thus, the ‘no evidence…”
Get full text

Multiple Sclerosis Incidence and Prevalence Trends in the Province of Padua, Northeast Italy, 1965-2018 by Grassivaro, Francesca, Puthenparampil, Marco, Pengo, Marta, Saiani, Martina, Venturini, Martina, Stropparo, Erica, Perini, Paola, Rinaldi, Francesca, Freddi, Nicoletta, Cadaldini, Morena, Colledan, Luisella, Piccinno, Maria Grazia, Pedrazzoli, Elisabetta, Gallo, Paolo

“…Previous studies, dating back to the 1960s disclosed a progressive increase in multiple sclerosis (MS) incidence and prevalence in the Province of Padua. To…”
Get more information

NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab fingolimod efficacy in multiple sclerosis by Marco Puthenparampil, Chiara Cazzola, Sofia Zywicki, Lisa Federle, Erica Stropparo, Mariagiulia Anglani, Francesca Rinaldi, Paola Perini, Paolo Gallo

“…Background: Cortical lesions (CLs) are typical of multiple sclerosis (MS) and have been recently incorporated in MS diagnostic criteria. Thus, the ‘no evidence…”
Get full text